Evidence map›Paper›PMID 32776673›Full record

ArticleInternational forum of allergy & rhinology2020

Olfactory training: what is the evidence?

Justin H Turner

Registry-linked trialAbstract readEditorial
In one paragraph

Article in International forum of allergy & rhinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05184192 (Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05184192 phase2completednot on this mapstarted 2022, after this paper: background citation

Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction

TypeinterventionalSponsorWashington University School of MedicineRan2022 to 2023Enrolled68ConditionsCOVID-19, Olfactory Disorder, Anosmia, HyposmiaArmsGabapentin gelatin capsules 300mg, Placebo
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Long-term olfactory loss post-COVID-19: Pathobiology and potential therapeutic strategies.World journal of otorhinolaryngology - head and neck surgery · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Olfactory Performance among Hospital Residents.International archives of otorhinolaryngology · 2022
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Justin H TurnerDepartment of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN.

Funding

Age-associated Innate Immune Dysfunction in Chronic RhinosinusitisR01AG065550 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TURNER, JUSTIN H · 2020 to 2024
$3.0M
Integrated Metagenomic and Metatranscriptomic Characterization of Inflammatory Chronic Rhinosinusitis EndotypesR21AI142321 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAS, SUMAN RANJAN, TURNER, JUSTIN H · 2020 to 2021
$924k
NIAID NIH HHS R21 AI142321NIA NIH HHS R01 AG065550
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Olfaction DisordersSmellHumansOdorantsOlfactory Bulb

Identifiers

PMID32776673
PMCPMC7668391

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.